Curis | CRIS - Capital Ordinário





Capital Ordinário Alterar Data
Alaunos Therapeutics USD 2.38M 172K 2026-03
Amgen USD 540M 1000K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
Bayer EUR 982.42M 0 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
CSL USD 482.13M 93.87M 2025-12
Curis USD 12.93M 12.87M 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Exelixis USD 253.7M 8.78M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-03
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Incyte USD 199.95M 1.49M 2026-03
Merck USD 2.47B 12.72M 2025-12
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.7B 13M 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
Takeda JPY 1.58B 241K 2026-03
TG Therapeutics USD 155.31M 95K 2025-12
Verastem USD 77.74M 77.74M 2025-12
Xoma USD 87K 1000 2024-06